ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
ABVC BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ABVC BioPharma's enterprise value was $27.46M on Nov 10, 2026, against $3.41B a year earlier. Over the last 5 years it ranged from $3.52M to $3.41B, with a median of $23.15M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $27.46M | -99.0% |
| 2025 | Dec 31, 2025 | $2.68B | +36896.5% |
| 2024 | Dec 31, 2024 | $7.25M | +38.9% |
| 2023 | Dec 29, 2023 | $5.22M | -73.9% |
| 2022 | Dec 30, 2022 | $19.99M | -77.6% |
| 2021 | Dec 31, 2021 | $89.14M | -15.0% |
| 2020 | Dec 31, 2020 | $104.90M | +22.0% |
| 2019 | Dec 31, 2019 | $86.02M | -79.3% |
| 2018 | Dec 31, 2018 | $415.73M | 0.0% |
| 2017 | Dec 29, 2017 | $415.73M | +1.4% |
| 2016 | Dec 30, 2016 | $410.07M | -89.9% |
| 2015 | Dec 31, 2015 | $4.04B | -96.3% |
| 2014 | Nov 28, 2014 | $110.48B | -20.0% |
| 2013 | Dec 31, 2013 | $138.11B | +671.2% |
| 2012 | Dec 31, 2012 | $17.91B | -94.4% |
| 2011 | Dec 30, 2011 | $322.35B | +705.4% |
| 2010 | Dec 31, 2010 | $40.03B | – |
See a number that looks wrong?